Clinical and economic outcomes for term infants associated with increasing administration of antibiotics to their mothers

Paediatric and Perinatal Epidemiology

Volumn 21, Issue 4, 2007, Pages 338-346

  Glasgow, Tiffany S ^a,c   Speakman, Mori ^b   Firth, Sean ^a,c   James, Brent ^b   Byington, Carrie L ^a,c   Young, Paul C ^a,c  

^a UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^b Institute for Health Care Delivery Research   (United States)

^c Intermountain Consortium for Child Health Services Research   (United States)

Author keywords

Antibiotic medication in labour; Caesarean section; Chorioamnionitis; Costs; Group B Streptococcal infection; Neonatal sepsis

Indexed keywords

AMPICILLIN;

ADULT; ANTIBIOTIC THERAPY; ARTICLE; CESAREAN SECTION; CHORIOAMNIONITIS; COST EFFECTIVENESS ANALYSIS; COST OF ILLNESS; DEMOGRAPHY; DRUG USE; FEMALE; GESTATIONAL AGE; HEALTH CARE ORGANIZATION; HOSPITAL ADMISSION; HUMAN; INFECTION PREVENTION; INTRAPARTUM CARE; LENGTH OF STAY; MAJOR CLINICAL STUDY; SEPSIS; STREPTOCOCCUS AGALACTIAE; TERM BIRTH; TREATMENT OUTCOME; VAGINAL DELIVERY;

ANTIBIOTIC PROPHYLAXIS; COSTS AND COST ANALYSIS; FEMALE; HUMANS; INFANT, NEWBORN; LENGTH OF STAY; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; PRENATAL CARE; SEPSIS; STREPTOCOCCAL INFECTIONS; STREPTOCOCCUS AGALACTIAE; TREATMENT OUTCOME;

EID: 34250192210     PISSN: 02695022     EISSN: 13653016     Source Type: Journal    
DOI: 10.1111/j.1365-3016.2007.00811.x     Document Type: Article

References (27)

1. American Academy of Pediatrics Committee on Infectious Diseases and Committee on Fetus and Newborn. Revised guidelines for prevention of early-onset group B streptococcal (GBS) infection. Pediatrics 1997 99 : 489 496.
2. Schrag S, Gorwitz R, Fultz-Butts K, Schuchat A. Prevention of perinatal group B streptococcal disease. Revised guidelines from CDC. Morbidity and Mortality Weekly Report. Recommendations and Reports 2002 51 [RR-18] : 1 22.
3. Schrag SJ, Zywicki S, Farley MM, Reingold AL, Harrison LH, Lefkowitz LB, et al. Group B streptococcal disease in the era of intrapartum antibiotic prophylaxis. New England Journal of Medicine 2000 342 : 15 20.
4. Peralta-Carcelen M, Fargason CA Jr, Cliver SP, Cutter GR, Gigante J, Goldenberg RL. Impact of maternal group B streptococcal screening on pediatric management in full-term newborns. Archives of Pediatrics and Adolescent Medicine 1996 150 : 802 808.
5. Mercer BM, Ramsey RD, Sibai BM. Prenatal screening for group B Streptococcus. II. Impact of antepartum screening and prophylaxis on neonatal care. American Journal of Obstetrics and Gynecology 1995 173 : 842 846.
6. Mercer BM, Ramsey RD, Sibai BM. Prenatal screening for group B Streptococcus. I. Impact of antepartum screening on antenatal prophylaxis and intrapartum care. American Journal of Obstetrics and Gynecology 1995 173 : 837 841.
7. Wiswell TE, Stoll BJ, Tuggle JM. Management of asymptomatic, term gestation neonates born to mothers treated with intrapartum antibiotics. Pediatric Infectious Disease Journal 1990 9 : 826 831.
8. Balter S, Zell ER, O'Brien KL, Roome A, Noga H, Thayu M, et al. Impact of intrapartum antibiotics on the care and evaluation of the neonate. Pediatric Infectious Disease Journal 2003 22 : 853 857.
9. Moore MR, Schrag SJ, Schuchat A. Effects of intrapartum antimicrobial prophylaxis for prevention of group-B-streptococcal disease on the incidence and ecology of early-onset neonatal sepsis. Lancet Infectious Diseases 2003 3 : 201 213.
10. James B. Quality improvement opportunities in health care. Making it easy to do it right. Journal of Managed Care Pharmacy 2002 8 : 394 399.
11. James BC. Implementing practice guidelines through clinical quality improvement. Frontiers of Health Services Management 1993 10 : 3 37 discussion 54 56.
12. James BC. Quality improvement in the hospital: managing clinical processes. Internist 1993 34 : 11 37.
13. Zeidel ML, James BC. Improving the quality of health care in America: what medical schools, leading medical journals, and federal funding agencies can do. American Journal of Medicine 2002 112 : 165 167.
14. Schrag SJ, Zell ER, Lynfield R, Roome A, Arnold KE, Craig AS, et al. A population-based comparison of strategies to prevent early-onset group B streptococcal disease in neonates. New England Journal of Medicine 2002 347 : 233 239.
15. Stoll BJ, Hansen N, Fanaroff AA, Wright LL, Carlo WA, Ehrenkranz RA, et al. Changes in pathogens causing early-onset sepsis in very-low-birth-weight infants. New England Journal of Medicine 2002 347 : 240 247.
16. Mercer BM, Carr TL, Beazley DD, Crouse DT, Sibai BM. Antibiotic use in pregnancy and drug-resistant infant sepsis. American Journal of Obstetrics and Gynecology 1999 181 : 816 821.
17. Escobar GJ. The neonatal 'sepsis work-up': personal reflections on the development of an evidence-based approach toward newborn infections in a managed care organization. Pediatrics 1999 103 : 360 373.
18. Luck S, Torny M, d'Agapeyeff K, Pitt A, Heath P, Breathnach A, et al. Estimated early-onset group B streptococcal neonatal disease. Lancet 2003 361 : 1953 1954.
19. Escobar GJ, Li DK, Armstrong MA, Gardner MN, Folck BF, Verdi JE, et al. Neonatal sepsis workups in infants >/=2000 grams at birth: a population-based study. Pediatrics 2000 106 : 256 263.
20. Rentz AC, Samore MH, Stoddard GJ, Faix RG, Byington CL. Risk factors associated with ampicillin-resistant infection in newborns in the era of group B streptococcal prophylaxis. Archives of Pediatrics and Adolescent Medicine 2004 158 : 556 560.
21. Laugel V, Kuhn P, Beladdale J, Donato L, Escande B, Astruc D, et al. Effects of antenatal antibiotics on the incidence and bacteriological profile of early-onset neonatal sepsis. A retrospective study over five years. Biology of the Neonate 2003 84 : 24 30.
22. Dillon HC Jr, Khare S, Gray BM. Group B streptococcal carriage and disease: a 6-year prospective study. Journal of Pediatrics 1987 110 : 31 36.
23. Baker CJ. Group B streptococcal infections. In : Infectious Disease of the Fetus and Newborn Infant, 5th edn. Editors : Remington JS, Klein JO. Philadelphia, PA : WB Saunders, 2001 pp. 1091 1156.
24. Prevention of perinatal group B streptococcal disease: a public health perspective. Morbidity and Mortality Weekly Report. Recommendations and Reports 1996 45 [RR-7] : 1 24.
25. Mohle-Boetani JC, Lieu TA, Ray GT, Escobar G. Preventing neonatal group B streptococcal disease: cost-effectiveness in a health maintenance organization and the impact of delayed hospital discharge for newborns who received intrapartum antibiotics. Pediatrics 1999 103 : 703 710.
26. Harbarth S, Gundlapalli AV, Stockdale W, Samore MH. Shortage of penicillin G: impact on antibiotic prescribing at a US tertiary care centre. International Journal of Antimicrobrial Agents 2003 21 : 484 487.
27. Glasgow T, Young PC, Wallin J, Kwok C, Stoddard G, Firth S, et al. Association of intrapartum antibiotic exposure and late-onset serious bacterial infection in infants. Pediatrics 2005 116 : 696 702.